Please assess the completion status of the following clinical trial:

Trial Title: Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Men and women ≥18 years of age at the time of the screening visit~2. Diagnosis of homozygous familial hypercholesterolemia (HoFH)~3. Willing to consistently maintain usual diet for the duration of the study~Exclusion Criteria:~1. Background medical lipid modifying therapy that has not been stable for at least 4 weeks (6 weeks for fibrates) prior to the screening visit~2. Having undergone lipid apheresis within 4 weeks prior to the screening visit~3. Use of another investigational drug or therapy within 30 days or at least 5 half-lives (whichever is longer) prior to the screening visit~4. Previous participation in any clinical trial of REGN1500~Note: The information listed above is not intended to contain all considerations relevant to a patient's potential participation in this clinical trial therefore not all inclusion/ exclusion criteria are listed.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Open-label (Type: EXPERIMENTAL): Open-label REGN1500

Based on this trial design, predict the completion outcome and termination type (if applicable).